Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study
- PMID: 22665813
- PMCID: PMC3554254
- DOI: 10.7326/0003-4819-156-11-201206050-00002
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study
Abstract
Background: Childhood cancer survivors develop gastrointestinal cancer more frequently and at a younger age than the general population, but the risk factors have not been well-characterized.
Objective: To determine the risk and associated risk factors for gastrointestinal subsequent malignant neoplasms (SMNs) in childhood cancer survivors.
Design: Retrospective cohort study.
Setting: The Childhood Cancer Survivor Study, a multicenter study of childhood cancer survivors diagnosed between 1970 and 1986.
Patients: 14 358 survivors of cancer diagnosed when they were younger than 21 years of age who survived for 5 or more years after the initial diagnosis.
Measurements: Standardized incidence ratios (SIRs) for gastrointestinal SMNs were calculated by using age-specific population data. Multivariate Cox regression models identified associations between risk factors and gastrointestinal SMN development.
Results: At median follow-up of 22.8 years (range, 5.5 to 30.2 years), 45 cases of gastrointestinal cancer were identified. The risk for gastrointestinal SMNs was 4.6-fold higher in childhood cancer survivors than in the general population (95% CI, 3.4 to 6.1). The SIR for colorectal cancer was 4.2 (CI, 2.8 to 6.3). The highest risk for gastrointestinal SMNs was associated with abdominal radiation (SIR, 11.2 [CI, 7.6 to 16.4]). However, survivors not exposed to radiation had a significantly increased risk (SIR, 2.4 [CI, 1.4 to 3.9]). In addition to abdominal radiation, high-dose procarbazine (relative risk, 3.2 [CI, 1.1 to 9.4]) and platinum drugs (relative risk, 7.6 [CI, 2.3 to 25.5]) independently increased the risk for gastrointestinal SMNs.
Limitation: This cohort has not yet attained an age at which risk for gastrointestinal cancer is greatest.
Conclusion: Childhood cancer survivors, particularly those exposed to abdominal radiation, are at increased risk for gastrointestinal SMNs. These findings suggest that surveillance of at-risk childhood cancer survivors should begin at a younger age than that recommended for the general population.
Primary funding source: National Cancer Institute.
Figures
Summary for patients in
-
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.Ann Intern Med. 2012 Jun 5;156(11):I-36. doi: 10.7326/0003-4819-156-11-201206050-00001. Ann Intern Med. 2012. PMID: 22665822 No abstract available.
Similar articles
-
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.Ann Intern Med. 2012 Jun 5;156(11):I-36. doi: 10.7326/0003-4819-156-11-201206050-00001. Ann Intern Med. 2012. PMID: 22665822 No abstract available.
-
Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.J Clin Oncol. 2019 Dec 1;37(34):3310-3319. doi: 10.1200/JCO.19.00129. Epub 2019 Oct 17. J Clin Oncol. 2019. PMID: 31622130 Free PMC article.
-
Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.J Clin Oncol. 2015 Nov 1;33(31):3568-75. doi: 10.1200/JCO.2015.60.9487. Epub 2015 Aug 10. J Clin Oncol. 2015. PMID: 26261260 Free PMC article.
-
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.J Clin Oncol. 2009 May 10;27(14):2356-62. doi: 10.1200/JCO.2008.21.1920. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255307 Free PMC article. Review.
-
Secondary malignant neoplasms in testicular cancer survivors.Urol Oncol. 2015 Sep;33(9):392-8. doi: 10.1016/j.urolonc.2015.05.002. Epub 2015 Jun 11. Urol Oncol. 2015. PMID: 26072728 Review.
Cited by
-
Screening and Surveillance of Colorectal Cancer: A Review of the Literature.Cancers (Basel). 2024 Aug 1;16(15):2746. doi: 10.3390/cancers16152746. Cancers (Basel). 2024. PMID: 39123473 Free PMC article. Review.
-
Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035.BMC Public Health. 2024 Jul 2;24(1):1763. doi: 10.1186/s12889-024-19104-6. BMC Public Health. 2024. PMID: 38956557 Free PMC article.
-
Therapy-Associated Polyposis, Late Presentation of a Childhood-Treated Disease.ACG Case Rep J. 2024 Jun 14;11(6):e01379. doi: 10.14309/crj.0000000000001379. eCollection 2024 Jun. ACG Case Rep J. 2024. PMID: 38883581 Free PMC article.
-
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention.Cancers (Basel). 2024 Apr 17;16(8):1530. doi: 10.3390/cancers16081530. Cancers (Basel). 2024. PMID: 38672612 Free PMC article. Review.
-
Risk Factors of Gastric Cancer and Lifestyle Modification for Prevention.J Gastric Cancer. 2024 Jan;24(1):99-107. doi: 10.5230/jgc.2024.24.e10. J Gastric Cancer. 2024. PMID: 38225769 Free PMC article. Review.
References
-
- Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29. - PubMed
-
- Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst. 2009;101(11):806–13. - PubMed
-
- Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA. 2011;305(22):2311–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources